+ All Categories
Home > Education > Cancer e staging standalone program keynote speech 2014

Cancer e staging standalone program keynote speech 2014

Date post: 07-Jul-2015
Category:
Upload: joe-cross
View: 99 times
Download: 0 times
Share this document with a friend
Description:
Keynote Speech MUA 2014
20
CANCER E-STAGING STANDALONE PROGRAM Dr Sanjoy Sanyal MBBS, MS, MSc (RCSEd), ADPHA Professor and Course Director [email protected] Patent Pending http://www.slideshare.net/sanyalsanjoy8/cance r-e-staging-standalone-program
Transcript
Page 1: Cancer e staging standalone program keynote speech 2014

CANCER E-STAGING STANDALONE PROGRAM

Dr Sanjoy SanyalMBBS, MS, MSc (RCSEd), ADPHA

Professor and Course [email protected]

Patent Pending

http://www.slideshare.net/sanyalsanjoy8/cancer-e-staging-standalone-program

Page 2: Cancer e staging standalone program keynote speech 2014

Abstract• Given the extreme complexity of grouping T, N, M

status of a tumor into its Stages, it is impossible to determine the Anatomical Stage of any cancer without the aid of complex TNM charts created by UICC.

• In order to render the process time- and user-friendly for the physician, an MS™ Excel-based e-Staging program was created for 26 cancers of human body.

• With just 5 mouse clicks one can arrive at the Stage of the cancer.

• This is a standalone tool, not requiring Internet connection, and can be used in a handheld device in any hospital or clinic.

Page 3: Cancer e staging standalone program keynote speech 2014

Background

• In the Union for International Cancer Control

(UICC) TNM classification, Tumor status (T) is

designated as T1, T2 etc, lymph Node

metastases (N) are designated as N0, N1 etc,

and distant Metastases (M) are designated as

M0, M1.

• For some cancers, like Seminoma of testis, Serum tumor marker (S) is an additional parameter.

Page 4: Cancer e staging standalone program keynote speech 2014

Background

• Each parameter may be further subdivided

into 'a', 'b' etc.

• The three (or four) major parameters are

grouped in increasing stages of cancer to give

the Anatomical Stage of the cancer,

designated by Roman numeral I, II etc.

• For many cancer, Stages may be subdivided

into 'A', 'B'.

Page 5: Cancer e staging standalone program keynote speech 2014

Process Flowchart for Creation of Cancer e-Staging Standalone Program

A multi-step process was used to create the e-Staging Program.

Page 6: Cancer e staging standalone program keynote speech 2014

Process Flowchart for Implementation of Cancer e-Staging Standalone Program

Page 7: Cancer e staging standalone program keynote speech 2014

Cancer e-Staging Standalone Program

• It has 6 electronic pages, requiring 5 mouse clicks

• Content page of the e-Staging tool gives a list of 26

cancers. It comes once we click on the Agree Tab

• Once on any Tumor page, the physician is asked to

successively select the appropriate T, N, M status of

that cancer.

• It takes the physician seamlessly through the 3

steps.

• Final page gives cancer Stage.

Page 8: Cancer e staging standalone program keynote speech 2014

Terms of Use Agreement

Page 9: Cancer e staging standalone program keynote speech 2014

Content Page of e-Staging Program

Second Mouse Click: Click on the cancer of choice, for which Staging is required

Page 10: Cancer e staging standalone program keynote speech 2014

Tumor (T) Page of e-Staging Program

Third Mouse Click: Click on the Tumor status (T) of the cancer for which Staging is required

Page 11: Cancer e staging standalone program keynote speech 2014

Node (N) Page of e-Staging Program

Fourth Mouse Click: Click on the Lymph Node status (N) of the cancer for which Staging is required

Page 12: Cancer e staging standalone program keynote speech 2014

Metastases (M) Page of e-Staging Program

Fifth Mouse Click: Click on the Metastasis status (M) of the cancer for which Staging is required

Page 13: Cancer e staging standalone program keynote speech 2014

Staging Page of e-Staging Program

Final Page: Gives the Anatomical Stage of the cancer for which Staging is required

Page 14: Cancer e staging standalone program keynote speech 2014

Uniqueness of e-Staging Program• This interactive e-Staging tool is standalone,

simpler (requiring only 5 mouse clicks),

quicker (just a few seconds) and easier than

those from others that are all Web-based.

• It can be used by any physician with minimum

computer skills.

• It is portable, can be used in any hand-held

device anywhere in the hospital or clinic, and

does not require Internet connection.

Page 15: Cancer e staging standalone program keynote speech 2014

Uniqueness of e-Staging Program• It eliminates consulting complicated TNM

charts, which are different for every tumor,

and also the need to rely on memory, thus

reducing errors and inconsistency between

physicians.

• The tool can be incorporated in a hospital

EMR with HL7.

• It is future-scalable, with options to add

more cancer sites to the system.

Page 16: Cancer e staging standalone program keynote speech 2014

Authorship and Conference Presentation• This paper and program was authored by Dr Sanjoy

Sanyal, Professor and Course Director of

Neuroscience in Medical University of the Americas, Nevis, St Kitts-Nevis, West Indies.

• It was accepted at the international Stanford

Medicine X Conference, and presented as a poster in Stanford University School of Medicine, LKSC Conference Center, 291 Campus Drive, Stanford, CA

94305-5101, USA, on 30 September, 2012. • Assistance of Medical University of the Americas in

preparing the poster is gratefully acknowledged.

Page 17: Cancer e staging standalone program keynote speech 2014

Stanford Medicine X Conference 2012

Page 18: Cancer e staging standalone program keynote speech 2014

Stanford Medicine X Conference 2012

Page 19: Cancer e staging standalone program keynote speech 2014

Stanford Medicine X Conference 2012

Page 20: Cancer e staging standalone program keynote speech 2014

PATENT STATUS

Provisional Patent Application accepted by United States Patent and Trademark Office (USPTO) in January 2014, giving it a 'Patent Pending' status.


Recommended